» Articles » PMID: 16239548

Immune Response to Pneumococcal Polysaccharides 4 and 14 in Elderly and Young Adults: Analysis of the Variable Heavy Chain Repertoire

Overview
Journal Infect Immun
Date 2005 Oct 22
PMID 16239548
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Streptococcus pneumoniae is a leading cause of morbidity and mortality in both developed and developing countries. The current pneumococcal polysaccharide (PPS) vaccine is highly effective in young adults; however, vaccine efficacy is dramatically decreased in the elderly population. We hypothesized that the decreased vaccine efficacy in the elderly results from altered variable gene family usage. We have characterized the immunoglobulin G gene usage of the antibody response to PPS4 and PPS14 in 20 young and 20 elderly adults. The variable heavy (V(H)) gene repertoire of human peripheral B cells was amplified by using PCR. A total of 364 heavy chain sequences with specificity for PPS4 and 305 heavy chain sequences for PPS14 were analyzed from young adults. In addition, a total of 325 sequences for PPS4 and 291 sequences for PPS14 were obtained from elderly adults. Complete sequence identity, somatic mutation frequencies, and V(H) gene usage was determined in response to PPS4 and PPS14. In all volunteers, the immune response to both polysaccharides consisted predominantly of heavy chains belonging to the V(H)3 gene family. There were significant differences in the variable gene repertoire between young and elderly adults. Somatic mutation occurred more frequently in sequences derived from young compared to elderly derived sequences. With aging, a loss of oligoclonality was noted in response to PPS4 and PPS14 compared to young adults. The observed differences in V(H) repertoire, somatic mutation, and loss of oligoclonality may contribute to decreased vaccine efficacy in the elderly.

Citing Articles

Carriers of the p.P522R variant in PLCγ2 have a slightly more responsive immune system.

Diks A, Teodosio C, de Mooij B, Groenland R, Naber B, de Laat I Mol Neurodegener. 2023; 18(1):25.

PMID: 37081539 PMC: 10116473. DOI: 10.1186/s13024-023-00604-9.


Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.

Babb R, Doyle C, Pirofski L Microbiol Spectr. 2021; 9(3):e0144621.

PMID: 34756090 PMC: 8579928. DOI: 10.1128/Spectrum.01446-21.


B-Cell Immunophenotyping to Predict Vaccination Outcome in the Immunocompromised - A Systematic Review.

Diks A, Overduin L, van Leenen L, Slobbe L, Jolink H, Visser L Front Immunol. 2021; 12:690328.

PMID: 34557188 PMC: 8452967. DOI: 10.3389/fimmu.2021.690328.


Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues.

Yang F, Nielsen S, Hoh R, Roltgen K, Wirz O, Haraguchi E Science. 2021; 372(6543):738-741.

PMID: 33846272 PMC: 8139427. DOI: 10.1126/science.abf6648.


Pneumococcal vaccination responses in adults with subnormal IgG subclass concentrations.

Parker A, Skold M, Harding S, Barton J, Bertoli L, Barton J BMC Immunol. 2019; 20(1):29.

PMID: 31429700 PMC: 6701150. DOI: 10.1186/s12865-019-0310-3.


References
1.
Nicoletti C, Yang X, Schulze D, cerny J . Repertoire diversity of antibody response to bacterial antigens in aged mice. II. Phosphorylcholine-antibody in young and aged mice differ in both VH/VL gene repertoire and in specificity. J Immunol. 1991; 147(8):2750-5. View

2.
Austrian R . Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis. 1981; 3 Suppl:S1-17. DOI: 10.1093/clinids/3.supplement_1.s1. View

3.
Sasso E, van Dijk K, Milner E . Prevalence and polymorphism of human VH3 genes. J Immunol. 1990; 145(8):2751-7. View

4.
Giudicelli V, Chaume D, Lefranc M . IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res. 2004; 33(Database issue):D256-61. PMC: 539964. DOI: 10.1093/nar/gki010. View

5.
Lucas A, Azmi F, Mink C, Granoff D . Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide. J Immunol. 1993; 150(5):2056-61. View